Changes At Israel's Drug Authority

30 January 1995

Israel's Ministry of Health is reported to have had no success so far in its search for a new director for its Pharmacy Division, with none of the candidates applying for the position deemed to be suitable, according to the Marketletter's Jerusalem correspondent.

Over the last six years, the Division has seen five directors come and go, and during the same period the Ministry has also had five different Ministers and four Directors-General.

The Pharmacy Division has two areas of responsibility, firstly for the registration of pharmaceuticals and devices to be produced and/or placed on the Israeli market, and also for the supervision of a range of pharmacy regulations which relate to the operating standards of pharmacies, warehouses and factories on a regional basis. The MoH has said in the past that it wishes to reorganize the Division and the operation of the regional pharmacists, and it has in recent years expanded the Division's activities to include the registration of devices. It has also increased the Divisional workforce at its headquarters in Jerusalem.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight